Referral for “Neoadjuvant Chemotherapy” for Muscle-Invasive Bladder Cancer to a Multidisciplinary Board: Patterns, Management and Outcomes
Athanasios Dellis,1 Roubini Zakopoulou,2 Andromahi Kougioumtzopoulou,3 Kimon Tzannis,2 Konstantinos Koutsoukos,2 Charalampos Fragkoulis,4 Efthymios Kostouros,5 Athanasios Papatsoris,6 Ioannis Varkarakis,6 Konstantinos Stravodimos,7 Eleni Boutati,8 Stamata Pagoni,5 Miltiadis Seferlis,9 Michael Chriso...
Main Authors: | Dellis A, Zakopoulou R, Kougioumtzopoulou A, Tzannis K, Koutsoukos K, Fragkoulis C, Kostouros E, Papatsoris A, Varkarakis I, Stravodimos K, Boutati E, Pagoni S, Seferlis M, Chrisofos M, Kouloulias V, Ntoumas K, Deliveliotis C, Constantinides C, Dimopoulos MA, Bamias A |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2021-07-01
|
Series: | Cancer Management and Research |
Subjects: | |
Online Access: | https://www.dovepress.com/referral-for-neoadjuvant-chemotherapy-for-muscle-invasive-bladder-canc-peer-reviewed-fulltext-article-CMAR |
Similar Items
-
A run-in phase clinical study for intravesical administration of durvalumab in patients with high-risk, non-muscle-invasive bladder cancer (NMIBC)
by: A. Papatsoris, et al.
Published: (2020-07-01) -
Clinical impact of combined PTEN and ERG rearrangements in localized prostate cancer
by: Charalampos Fragkoulis, et al.
Published: (2021-03-01) -
Hyberbaric oxygen as sole treatment for severe radiation - induced haemorrhagic cystitis
by: Athanasios Dellis, et al. -
Reducing the number of sutures for vesicourethral anastomosis in radical retropubic prostatectomy
by: Evangelos M. Mazaris, et al.
Published: (2009-04-01) -
Serum testosterone as a biomarker for second prostatic biopsy in men with negative first biopsy for prostatic cancer and PSA>4ng/mL, or with PIN biopsy result
by: Alexandros Fiamegos, et al.